MedPath

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Phase 3
Completed
Conditions
Asthma
Interventions
Registration Number
NCT00073840
Lead Sponsor
Sumitomo Pharma America, Inc.
Brief Summary

The primary objective of this study is to investigate the efficacy of levalbuterol 90 ug (2 actuations, 45 ug each) versus placebo (2 actuations) in the treatment and prevention of bronchoconstriction in adolescent and adult subjects with asthma, with all treatments administered 4 times a day (QID).

Detailed Description

A double-blind, randomized, placebo- and active-controlled, multicenter, parallel-group trial of levalbuterol in subjects 12 years of age and older with asthma. Study participation will include one 1-week single-blind placebo run-in and an 8-week, randomized,double-blind, active-treatment period with four treatment groups. This study was previously posted by Sepracor Inc. In October 2009, Sepracor Inc. was acquired by Dainippon Sumitomo Pharma., and in October 2010, Sepracor Inc's name was changed to Sunovion Pharmaceuticals Inc.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
386
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IlevalbuterolLevalbuterol 90 ųg QID (manufacturing site A or B)
IIIlevalbuterolPlacebo QID
IIlevalbuterolRacemic Albuterol 180 ųg QID
Primary Outcome Measures
NameTimeMethod
FEV1 (peak percent change from pre-dose averaged over the double-blind period).8 weeks
Secondary Outcome Measures
NameTimeMethod
--FEV1 [area under the % change from pre-dose FEV1 curve] and FEV1 [area under the % change from study baseline FEV1 curve]9 weeks

Trial Locations

Locations (54)

Allergy & Asthma Center, LLC

🇺🇸

Oxford, Alabama, United States

Alta Clinical Research

🇺🇸

Tucson, Arizona, United States

Integrated Research Group

🇺🇸

Corona, California, United States

Radiant Research, Inc.

🇺🇸

Encinitas, California, United States

Allergy & Asthma Specialists Medical Group

🇺🇸

Huntington Beach, California, United States

Asthma, Allergy & Respiratory Care Center

🇺🇸

Long Beach, California, United States

Allergy Research Foundation, Inc.

🇺🇸

Los Angeles, California, United States

Madera Family Medical Group

🇺🇸

Madera, California, United States

Southern California Research

🇺🇸

Mission Viejo, California, United States

Comprehensive Allergy Services

🇺🇸

Oakland, California, United States

Scroll for more (44 remaining)
Allergy & Asthma Center, LLC
🇺🇸Oxford, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.